Yahoo Suche Web Suche

Anmelden

Suchergebnisse

  1. Suchergebnisse:

  1. www.businesswire.com › news › homeConfo Therapeutics Appoints Dieter Weinand, Former CEO of Bayer...

    29. Aug. 2023 · Weinand holds a B.A. in Biology from Concordia College, New York, and an M.S. in Pharmacology and Toxicology from Long Island University, New York. Mr. Weinand is Chairman of the Board of...

  2. www.biospace.com › article › releasesConfo Therapeutics Appoints Dieter Weinand, Former CEO of Bayer...

    29. Aug. 2023 · Weinand holds a B.A. in Biology from Concordia College, New York, and an M.S. in Pharmacology and Toxicology from Long Island University, New York. Mr. Weinand is Chairman of the Board of Nasdaq-listed Replimune (REPL), FORE Biotherapeutics, and ZielBio, among others. About Confo Therapeutics.

  3. Bilder

    • Dieter Weinand | Long Island University
    • Long Island University
    • Dieter Weinand to become President of Bayer HealthCare Pharmaceuticals
    • Digitization’s Impact on the Pharmaceutical Industry | CHEManager
    • Replimune Appoints Dieter Weinand as Chairman and Paolo Pucci to the ...

    Alle anzeigen

  4. www.confotherapeutics.com › 2023/08/29 › confo-therapeuticsConfo Therapeutics Appoints Dieter Weinand, Former CEO of Bayer...

    29. Aug. 2023 · Mr. Weinand holds a B.A. in Biology from Concordia College, New York, and an M.S. in Pharmacology and Toxicology from Long Island University, New York. Mr. Weinand is Chairman of the Board of Nasdaq-listed Replimune (REPL), FORE Biotherapeutics, and ZielBio, among others. About Confo Therapeutics

  5. fore.bio › people › dieter-weinandDieter Weinand - Fore Biotherapeutics

    Chairman of the Board. Dieter Weinand is the former CEO of Bayer Pharma AG, and is an experienced business leader with over 25 years of experience in the pharmaceutical industry. He earned an M.S. in pharmacology and toxicology from Long Island University, New York, and a B.A. in biology from Concordia College, New York.

  6. www.umoja-biopharma.com › news › umoja-biopharma-appointsUmoja Biopharma Appoints Dieter Weinand as the Chair of its Board...

    Dieter Weinand is the former CEO of Bayer Pharma AG and is an experienced business leader with over 25 years of experience in the pharmaceutical industry. He earned an M.S. in pharmacology and toxicology from Long Island University, New York, and a B.A. in biology from Concordia College, New York.

  7. www.umoja-biopharma.com › team › dieter-weinandDieter Weinand | Umoja Biopharma

    Dieter Weinand is the former CEO of Bayer Pharma AG and is an experienced business leader with over 25 years of experience in the pharmaceutical industry. Mr. Weinand earned an M.S. in pharmacology and toxicology from Long Island University, New York, and a B.A. in biology from Concordia College, New York.

  8. www.pharmiweb.com › press-release › 2023/08/21Former CEO and Chairman of the Board of Bayer Pharma AG, Dieter...

    21. Aug. 2023 · Former CEO and Chairman of the Board of Bayer Pharma AG, Dieter Weinand, Joins Coya’s Board of Directors. Mr. Weinand is the former CEO and Chairman of the Board at Bayer Pharma AG, leading Bayer’s fully integrated $20 billion healthcare business.